I typically combine it with TB-500 because they support different aspects of the healing process
Most GLP-1 medications are FDA-approved for people who are overweight or obese and have at least one weight-related problem like high blood pressure or high cholesterol
In some cases, insurance doesn't even cover brand-name semaglutide formulations
In contrast, GLP-1 receptors agonists which besides their insulin stimulating effect also suppress glucagon secretion and appetite appear to be an attractive alternative
And once it's in the fat cell, it's too big to get down, unless you break it down into fatty acids and glycerol again, and the way you do that is with a hormone called hormone -sensitive lipase, and insulin inhibits that
In Novo Nordisk clinical trials it is being tested in combination with semaglutide (CagriSema) in Phase 3 obesity trials